We are looking for children 2 to 17 years of age to join a trial to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe ulcerative colitis (including associated symptoms such as diarrhea, unexplained weight loss, cramps, malnutrition and/or liver disease), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the GI clinical research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
